Vaxcyte Inc. (NASDAQ: PCVX) open the trading on May 24, 2023, with great promise as it jumped 0.87% to $50.94. During the day, the stock rose to $51.41 and sunk to $49.1901 before settling in for the price of $50.50 at the close. Taking a more long-term approach, PCVX posted a 52-week range of $17.44-$54.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its Annual Earning per share during the time was -57.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -78.70%. This publicly-traded company’s shares outstanding now amounts to $86.21 million, simultaneously with a float of $72.19 million. The organization now has a market capitalization sitting at $4.81 billion. At the time of writing, stock’s 50-day Moving Average stood at $43.00, while the 200-day Moving Average is $38.81.
Vaxcyte Inc. (PCVX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Vaxcyte Inc.’s current insider ownership accounts for 0.60%, in contrast to 74.10% institutional ownership. According to the most recent insider trade that took place on Jan 10, this organization’s Director sold 315 shares at the rate of 46.12, making the entire transaction reach 14,526 in total value, affecting insider ownership by 3,125. Preceding that transaction, on Dec 12, Company’s Director sold 335 for 43.93, making the whole transaction’s value amount to 14,717. This particular insider is now the holder of 3,125 in total.
Vaxcyte Inc. (PCVX) Earnings and Revenue Records
So, what does the last quarter earnings report of the company that was made public on 3/30/2023 suggests? It has posted -$0.7 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.83) by $0.13. This company achieved a return on equity of -36.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.
Vaxcyte Inc.’s EPS decrease for this current 12-month fiscal period is -78.70% and is forecasted to reach -3.35 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 1.20% through the next 5 years, which can be compared against the -57.40% growth it accomplished over the previous five years trading on the market.
Vaxcyte Inc. (NASDAQ: PCVX) Trading Performance Indicators
Let’s observe the current performance indicators for Vaxcyte Inc. (PCVX). It’s Quick Ratio in the last reported quarter now stands at 15.90. The Stock has managed to achieve an average true range (ATR) of 2.14.
In the same vein, PCVX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.42, a figure that is expected to reach -0.74 in the next quarter, and analysts are predicting that it will be -3.35 at the market close of one year from today.
Technical Analysis of Vaxcyte Inc. (PCVX)
[Vaxcyte Inc., PCVX] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 59.72% While, its Average True Range was 2.09.
Raw Stochastic average of Vaxcyte Inc. (PCVX) in the period of the previous 100 days is set at 81.19%, which indicates a major rise in contrast to 47.06% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 41.77% that was lower than 48.06% volatility it exhibited in the past 100-days period.
